Comparison of intrathecal morphine and epidural bupivacaine analgesia for post operative analgesia after elective abdominal hysterectomy by Nayan, Anafairos Md
I 
 
 
COMPARISON OF INTRATHECAL MORPHINE AND EPIDURAL BUPIVACAINE 
ANALGESIA FOR POST OPERATIVE ANALGESIA AFTER ELECTIVE ABDOMINAL 
HYSTERECTOMY 
 
 
 
By 
DR ANAFAIROS BINTI MD NAYAN 
MD (USM) 
 
 
 
 
MANUSCRIPT SUBMITTED IN PARTIAL FULLFILLMENT OF THE REQUIREMENTS 
FOR THE DEGREE OF MASTERS OF MEDICINE 
(ANAESTHESIOLOGY) 
 
 
 
 
UNIVERSITI SAINS MALAYSIA 
2016 
  
  
II 
 
ACKNOWLEDGEMENT 
I would like to take this opportunity to thank everyone who was involved in making this 
manuscript possible. 
First of all, I would like to express my gratitude to my supervisor, Dr Wan Nazaruddin bin 
Wan Hassan for his support, encouragement, advice and guide in completing this manuscript. 
Special thanks to my co-supervisor, Dr Azmi bin Abu Hassan and Dr Rhendra Hardy bin 
Mohamad Zaini for their continuous support and courage. 
Special thanks to all lecturers and colleagues from Department of Anesthesiology, Hospital 
University Sains Malaysia (HUSM) for their help and understanding. I also want to record 
my appreciation to Acute Pain Service nurses, operation theatre staffs and all nurses from 
wards that had help me during data collection and patient’s review. 
Finally, special thanks to my family for their unconditional love and patience. 
Thank you.  
  
III 
 
 
TABLE OF CONTENTS 
 
 
CONTENT 
 
PAGE 
Title  
 
I 
Acknowledgement  
 
II 
Table of contents 
 
                  III 
List of tables 
 
IV 
Abbreviations  
 
                  V 
Chapter 1: Introduction 
 
1 – 7 
Chapter 2: Study protocol 
 Document submitted for ethical approval 
 
 Ethical approval letter 
 
 
8 - 42 
 
43 - 49 
Chapter 3: Selected journal format 
 
50 – 67 
Chapter 4: Body (Manuscript) 
 
 
i Title 
 
68 
ii Abstract 
 
68 – 69 
iii Introduction 
 
70 – 71 
iv Methodology 
 
72 – 73 
v Results 
 
74 
vi Discussion 
 
75 – 77 
vii Conclusion 78 
 
viii References 
 
79 – 80 
ix Correspondence  
 
81 
x Tables 82 – 85 
 
Chapter 5: Appendix 
 
86 – 88 
 
  
IV 
 
 
LIST OF TABLES 
 
TABLE  PAGE 
 
Table 1  Demographic data 
 
                  82 
Table 2 The post-operative pain score over 24 hours 
 
83 
 
Table 3 The comparison of mean difference total morphine 
consumption, time to early mobilization, length of stay 
and time for first PCA morphine demand 
 
84 
 
 
 
Table 4 The side effects 85 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
V 
 
 
ABBREVIATIONS 
 
ITM Intrathecal Morphine 
 
EA Epidural analgesia 
 
HUSM Hospital Universiti Sains Malaysia 
 
VAS Visual Analogue Scale 
 
IV Intravascular 
 
PCA Patient Controlled Analgesia 
 
ASA American Society of Anesthesiologists (Physical Status) 
 
OT Operation theatre 
 
ECG Electrocardiogram 
 
ETT Endotracheal tube 
 
GA General Anesthesia 
 
 
 
 
 
 
 
 
 
 
 
1 
 
 
CHAPTER 1: INTRODUCTION 
Abdominal hysterectomy is the surgical removal of the uterus which may also involve
 removal of the cervix, ovaries, fallopian tubes and other surrounding structures. It is one of t
he most commonly performed gynaecological surgical procedures. The pain after this surgery
 is severe and the role of an effective post operative analgesia is very important for patient’s c
omfort, haemodynamic stability, early ambulation and shorter hospital stay. 
Epidural analgesia was one of the common techniques for post operative analgesia aft
er this surgery and was previously thought to be gold standard analgesia. This technique is be
neficial in reduction of cardiovascular and pulmonary complications.  However, this procedur
e is more invasive which requires placement of catheter in epidural space. The placement of t
he epidural catheter may be time consuming, possibility of failure during insertion, may be co
ntraindicated and pose several side effects. In patients who are potential to develop coagulopa
thy or require anti coagulant therapy, proper timing of epidural catheter removal can be affect
ed and there is a potential risk of epidural haematoma.  
Nowadays, with the present of other options and less invasive techniques, the options 
of analgesia for abdominal hysterectomy are wider. Intrathecal morphine (ITM) is one of the 
other potential alternatives to epidural. It has the advantages of being a single injection, easy t
o perform, less time consuming, safer technique and cost effective compared to epidural. This
 technique has been proven in previous studies as a good option to epidural analgesia in liver 
surgery and caesarean section but there is limited data for gynaecological surgery.  
The aims of the study are to compare the analgesic efficacy between ITM and epidural 
bupivacaine for post operative analgesia undergoing elective abdominal hysterectomy. 
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LITERATURE REVIEW 
 
Intrathecal morphine (ITM) for gynaecological surgery 
 
Hein, A. et al. (2012) conducted a randomized placebo-controlled study on low dose 
ITM effects on post-hysterectomy pain. They compared the effects of morphine 0, 100, 200, 
or 300 mug added to intrathecal bupivacaine on first post-operative 24 h patient-controlled 
analgesia morphine (PCA-morphine) consumption after abdominal hysterectomy under 
general anaesthesia in 144 patients. Results showed that ITM reduced accumulated 24 h post-
operative morphine consumption. Morphine 100 mug significantly reduced morphine 
consumption vs. placebo at 0-6 h, 6-12 h, and for the entire 0-24 h time interval post-
operation. Morphine 200 mug further significantly reduced morphine consumption vs. 
morphine 100 mug at 0-6 h and for the entire 0-24 h post-operation. There was no further 
reduction of morphine consumption seen with morphine 300 mug. No serious side effects 
were seen. Emesis was similar in all groups, and pruritus was experienced only in the 
morphine groups. The study concluded that ITM supplementation to bupivacaine reduces 
first 24 h PCA-morphine consumption after abdominal hysterectomy under general 
anaesthesia, and they found no benefit from increasing the dose over 200 mug (1). 
 
Rebel, A. et al. (2011) retrospectively studied on high-dose intrathecal morphine for 
analgesia after pelvic surgery. The effectiveness of intrathecal opioids (ITOs) for 
postoperative analgesia has been limited by reduced opioid dosing because of opioid-related 
side effects, most importantly respiratory depression. To overcome these limitations, this 
study compared combination of high-dose intrathecal morphine with a continuous 
intravenous (IV) postoperative naloxone infusion with IV opioid analgesia alone. They 
concluded that high-dose IT opioids in combination with a postoperative IV naloxone 
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infusion provided excellent analgesia for major pelvic surgery. The IV naloxone infusion 
combined with high-dose ITOs appeared to control opioid side effects without affecting 
analgesia (2). 
 
Massicotte, L. et al. (2009) conducted a study to compare morphine consumption with 
patient-controlled analgesia (PCA) between spinal anesthesia (SA) (bupivacaine, morphine 
and fentanyl) and general anesthesia (GA) (sufentanil) after an abdominal hysterectomy. 40 
women were randomly assigned to receive SA with bupivacaine 15 mg, 0.15 mg of 
intrathecal morphine and 15 microg of fentanyl or GA with sufentanil, both combined with 
PCA. It was concluded that intrathecal morphine 0.15 mg with 15 microg of fentanyl 
decreases post-operative pain and morphine consumption by PCA without increasing adverse 
reactions for women undergoing an abdominal hysterectomy. Post operative care unit 
(PACU) and hospital stay were also significantly reduced in SA group (3). 
 
Niruthisard, S et al (2007) studied the effect of IV parecoxib in addition to intrathecal 
morphine and bupivacaine. The results showed that the addition of parecoxib to intrathecal 
morphine and bupivacaine significantly reduced cumulative morphine consumption, Visual 
Analog Pain scores, and increased patient satisfaction for 24 h postoperatively without an 
obvious decrease of adverse side effects (4).  
 
Karaman, S. et al. (2006) studied on the effects of preoperative intrathecal morphine on 
perioperative hemodynamics, stress response, and postoperative analgesia was evaluated in 
patients undergoing abdominal hysterectomy with general anesthesia. A total of 24 patients 
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were randomly assigned to the morphine group (n=12) or the control group (n=12). Patients 
in the morphine group were given intrathecal 5 microg/kg(-1) morphine before surgery. In all 
patients, general anesthesia was induced and all patients received intravenous morphine 
patient-controlled analgesia after surgery. Intra operative hemodynamic was similar in both 
groups, but postoperative HR and MAP values at 4 h, 8 h, 12 h, and 20 h were significantly 
lower in the morphine group (P<.05). Postoperative VAS scores, total morphine 
consumption, and plasma epinephrine, norepinephrine, and glucose levels were significantly 
lower in the morphine group than in the control group (P<.05). This study concluded that 
preoperative intrathecal morphine enhanced the quality of postoperative analgesia, decreased 
morphine consumption, and depressed the systemic stress response in patients undergoing 
total abdominal hysterectomy with general anesthesia (5). 
 
 Intrathecal morphine (ITM) versus epidural analgesia (EA) 
 
Kasivisvanathan, R. et al. (2014) conducted a prospective observational study to compare 
peri/post-operative outcomes of thoracic epidural analgesia (TEA) versus intrathecal 
morphine and fentanyl patient-controlled analgesia (ITM+fPCA) for 73 patients undergoing a 
hepatic resection (36 TEA and 37 ITM+fPCA). The median (IQR) post-operative LoS was 13 
(11-15) and 11 (9-13) days in the TEA and ITM+fPCA groups, respectively (P = 0.011). 
There was significantly lower median intra-operative central venous pressure (P < 0.001) and 
blood loss (P = 0.017) in the TEA group, and a significant reduction in the time until 
mobilization (P < 0.001), post-operative intra-venous fluid/vasopressor requirement (P < 
0.001/P = 0.004) in the ITM+fPCA group. Pain scores were lower at a clinically significant 
level 12 h post-operatively in the TEA group (P < 0.001); otherwise there were no differences 
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out to day five. There were no differences in quality of recovery or postoperative 
morbidity/mortality between the two groups (6).  
 
Mercadante, S. et al. (2008) conducted a randomized-controlled study of intrathecal versus 
epidural thoracic analgesia in patients undergoing abdominal cancer surgery. They concluded 
that ITA and ETA produced the same levels of analgesia, without relevant complications (7). 
 
De Pietri, L. et al (2006) studied the use of intrathecal morphine for postoperative pain relief 
after liver resection in comparison with epidural analgesia. In this study, they tested a single-
shot intrathecal morphine technique and compared it to a continuous epidural naropine 
infusion for postoperative analgesia in liver surgery. Fifty patients were randomly assigned to 
an epidural analgesia group (EP group; n = 25) and an intrathecal analgesia group (IN group; 
n = 25). The quality of analgesia assessed by a visual analogue scale (VAS), the side effects, 
and the additional IV analgesic requirements were recorded. They did not observe any signs 
of cord compression. Time to first pain drug requirement was longer in the EP group 
compared to the IN group (25 +/- 18.5 h versus 12 +/- 10.3 h; P < 0.05). In both groups, the 
VAS remained less than 30 mm throughout the 48-h follow-up period. Consumption of IV 
morphine with a patient-controlled analgesia device in the IN group was larger (mostly from 
24 to 48 h after surgery) than the EP group (12.0 +/- 5.54 mg versus 3.1 +/- 2.6 mg, 
respectively; P < 0.01). The incidence of vomiting was 4% in both groups, whereas the 
incidence of pruritus (16% versus 0%) and nausea (16% versus 4%) was more frequent in the 
IN group. No postdural puncture headache and no spinal hematoma occurred. They 
concluded that a single dose of intrathecal morphine followed by patient-controlled morphine 
analgesia can provide satisfactory postoperative pain relief after liver resection. The quality 
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of this treatment, according to the VAS, is not inferior to continuous epidural analgesia up to 
48 h after surgery (8). 
 
Duale, C. et al. (2003) studied on epidural versus intrathecal morphine for postoperative 
analgesia after Caesarean section. Combined spinal-epidural anaesthesia with 6 mg of IT 
hyperbaric bupivacaine plus sufentanil 5 microg, and additional ED lidocaine was used. 
Additionally, each patient received either 2 mg (2 ml) of ED morphine plus 1 ml of IT 
normal saline (ED group, n=28), or 0.075 mg (1 ml) of IT Morphine plus 2 ml of ED normal 
saline (IT group, n=25). Additional postoperative analgesia was given in the form of 
propacetamol and ketoprofen, plus self-administered IV morphine. Results showed that; no 
major respiratory depression occurred. Time to first demand of morphine was similar in the 
ED (307.5 min) and IT (310 min) groups, as was the incidence of side-effects such as 
sedation, pruritus, nausea, and vomiting. During the first 24 postoperative hours, VAS pain 
scores were greater in the IT group (P=0.032), as was additional morphine consumption (4 vs 
1.5 mg) (P=0.03). The study concluded that the ED protocol was more effective than the IT 
protocol, whilst side-effects were similar (9). 
 
Abouleish, E et al (1991) conducted a study to compare the efficacy and side effects of 0.2 
mg intrathecal (IT) morphine with 0.125% epidural bupivacaine in 62 women in labor. They 
were randomly divided into three groups: group 1 (n = 20) received IT morphine; group 2 (n 
= 22) received epidural bupivacaine; and group 3 (n = 20) received a combination of both 
using a combined spinal-epidural (CSE) technique. According to a visual analogue scale for 
assessing analgesia, neither IT 0.2 mg morphine nor 10 ml 0.125% epidural bupivacaine was 
effective in producing adequate pain relief in labor, whereas the combination produced 
excellent analgesia. The use of IT morphine significantly reduced the dosage requirement of 
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epidural bupivacaine. The incidence of nausea, vomiting, and pruritus was significantly 
higher when IT morphine had been administered, whereas that of urinary retention did not 
differ. No serious respiratory depression occurred in any of the patients. When the course of 
labor was studied, the prior use of IT morphine significantly prolonged the duration of the 
first stage of labor and the total duration of labor. They conclude that the administration of 
0.2 mg IT morphine in combination with epidural administration of 0.125% bupivacaine 
provides better analgesia than the administration of either drug alone (10). 
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INTRODUCTION 
Abdominal hysterectomy is the surgical removal of the uterus which may also involve
 removal of the cervix, ovaries, fallopian tubes and other surrounding structures. It is one of t
he most commonly performed gynaecological surgical procedures. The pain after this surgery
 is severe and the role of an effective post operative analgesia is very important for patient’s c
omfort, haemodynamic stability, early ambulation and shorter hospital stay. 
Epidural analgesia was one of the common techniques for post operative analgesia aft
er this surgery and was previously thought to be gold standard analgesia. This technique is be
neficial in reduction of cardiovascular and pulmonary complications.  However, this procedur
e is more invasive which requires placement of catheter in epidural space. The placement of t
he epidural catheter may be time consuming, carries failure possibility, may be contraindicate
d and pose several side effects. In patients who are potential to develop coagulopathy or requi
re anti coagulant therapy, proper timing of epidural catheter removal can be affected and ther
e is a potential risk of epidural haematoma.  
Nowadays, with the present of other options and less invasive techniques, the options 
of analgesia for abdominal hysterectomy are wider. Intrathecal morphine (ITM) is one of the 
other potential alternatives to epidural. It has the advantages of being a single injection, easy t
o perform, less time consuming, safer technique and cost effective compared to epidural. This
 technique has been proven in previous studies as a good option to epidural analgesia in liver 
surgery and caesarean section but there is limited data for gynaecological surgery.  
The aims of the study are to compare the analgesic efficacy between ITM and epidura
l bupivacaine (EB) for post operative analgesia undergoing elective abdominal hysterectomy.
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LITERATURE REVIEW 
 
Intrathecal morphine (ITM) for gynaecological surgery 
 
Hein, A. et al. (2012) conducted a randomized placebo-controlled study on low dose 
ITM effects on post-hysterectomy pain. They compared the effects of morphine 0, 100, 200, 
or 300 mug added to intrathecal bupivacaine on first post-operative 24 h patient-controlled 
analgesia morphine (PCA-morphine) consumption after abdominal hysterectomy under 
general anaesthesia in 144 patients. Results showed that ITM reduced accumulated 24 h post-
operative morphine consumption. Morphine 100 mug significantly reduced morphine 
consumption vs. placebo at 0-6 h, 6-12 h, and for the entire 0-24 h time interval post-
operation. Morphine 200 mug further significantly reduced morphine consumption vs. 
morphine 100 mug at 0-6 h and for the entire 0-24 h post-operation. There was no further 
reduction of morphine consumption seen with morphine 300 mug. No serious side effects 
were seen. Emesis was similar in all groups, and pruritus was experienced only in the 
morphine groups. The study concluded that ITM supplementation to bupivacaine reduces 
first 24 h PCA-morphine consumption after abdominal hysterectomy under general 
anaesthesia, and they found no benefit from increasing the dose over 200 mug (1). 
 
Rebel, A. et al. (2011) retrospectively studied on high-dose intrathecal morphine for 
analgesia after pelvic surgery. The effectiveness of intrathecal opioids (ITOs) for 
postoperative analgesia has been limited by reduced opioid dosing because of opioid-related 
side effects, most importantly respiratory depression. To overcome these limitations, this 
study compared combination of high-dose intrathecal morphine with a continuous 
intravenous (IV) postoperative naloxone infusion with IV opioid analgesia alone. They 
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concluded that high-dose IT opioids combined with a postoperative IV naloxone infusion 
provided excellent analgesia for major pelvic surgery. The IV naloxone infusion combined 
with high-dose ITOs appeared to control opioid side effects without affecting analgesia (2). 
 
Massicotte, L. et al. (2009) conducted a study to compare morphine consumption with 
patient-controlled analgesia (PCA) between spinal anesthesia (SA) (bupivacaine, morphine 
and fentanyl) and general anesthesia (GA) (sufentanil) after an abdominal hysterectomy. 40 
women were randomly assigned to receive SA with bupivacaine 15 mg, 0.15 mg of 
intrathecal morphine and 15 microg of fentanyl or GA with sufentanil, both combined with 
PCA. It was concluded that intrathecal morphine 0.15 mg with 15 microg of fentanyl 
decreases post-operative pain and morphine consumption by PCA without increasing adverse 
reactions for women undergoing an abdominal hysterectomy. Post operative care unit 
(PACU) and hospital stay were also significantly reduced in SA group (3). 
 
Niruthisard, S et al (2007) studied the effect of IV parecoxib in addition to intrathecal 
morphine and bupivacaine. The results showed that the addition of parecoxib to intrathecal 
morphine and bupivacaine significantly reduced cumulative morphine consumption, Visual 
Analog Pain scores, and increased patient satisfaction for 24 h postoperatively without an 
obvious decrease of adverse side effects (4).  
 
Karaman, S. et al. (2006) studied on the effects of preoperative intrathecal morphine on 
perioperative hemodynamics, stress response, and postoperative analgesia was evaluated in 
patients undergoing abdominal hysterectomy with general anesthesia. A total of 24 patients 
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were randomly assigned to the morphine group (n=12) or the control group (n=12). Patients 
in the morphine group were given intrathecal 5 microg/kg (-1) morphine before surgery. In 
all patients, general anesthesia was induced and all patients received intravenous morphine 
patient-controlled analgesia after surgery. Intraoperative hemodynamics was similar in both 
groups, but postoperative HR and MAP values at 4 h, 8 h, 12 h, and 20 h were significantly 
lower in the morphine group (P<.05). Postoperative VAS scores, total morphine 
consumption, and plasma epinephrine, norepinephrine, and glucose levels were significantly 
lower in the morphine group than in the control group (P<.05). This study concluded that 
preoperative intrathecal morphine enhanced the quality of postoperative analgesia, decreased 
morphine consumption, and depressed the systemic stress response in patients undergoing 
total abdominal hysterectomy with general anesthesia (5). 
 
 Intrathecal morphine (ITM) versus epidural analgesia (EA) 
 
Kasivisvanathan, R. et al. (2014) conducted a prospective observational study to compare 
peri/post-operative outcomes of thoracic epidural analgesia (TEA) versus intrathecal 
morphine and fentanyl patient-controlled analgesia (ITM+fPCA) for 73 patients undergoing a 
hepatic resection (36 TEA and 37 ITM+fPCA). The median (IQR) post-operative LoS was 13 
(11-15) and 11 (9-13) days in the TEA and ITM+fPCA groups, respectively (P = 0.011). 
There was significantly lower median intra-operative central venous pressure (P < 0.001) and 
blood loss (P = 0.017) in the TEA group, and a significant reduction in the time until 
mobilization (P < 0.001), post-operative intra-venous fluid/vasopressor requirement (P < 
0.001/P = 0.004) in the ITM+fPCA group. Pain scores were lower at a clinically significant 
level 12 h post-operatively in the TEA group (P < 0.001); otherwise there were no differences 
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out to day five. There were no differences in quality of recovery or postoperative 
morbidity/mortality between the two groups (6).  
 
Mercadante, S. et al. (2008) conducted a randomized-controlled study of intrathecal versus 
epidural thoracic analgesia in patients undergoing abdominal cancer surgery. They concluded 
that ITA and ETA produced the same levels of analgesia, without relevant complications (7). 
 
De Pietri, L. et al (2006) studied the use of intrathecal morphine for postoperative pain relief 
after liver resection in comparison with epidural analgesia. In this study, they tested a single-
shot intrathecal morphine technique and compared it to a continuous epidural naropine 
infusion for postoperative analgesia in liver surgery. Fifty patients were randomly assigned to 
an epidural analgesia group (EP group; n = 25) and an intrathecal analgesia group (IN group; 
n = 25). The quality of analgesia assessed by a visual analogue scale (VAS), the side effects, 
and the additional IV analgesic requirements were recorded. They did not observe any signs 
of cord compression. Time to first pain drug requirement was longer in the EP group 
compared to the IN group (25 +/- 18.5 h versus 12 +/- 10.3 h; P < 0.05). In both groups, the 
VAS remained less than 30 mm throughout the 48-h follow-up period. Consumption of IV 
morphine with a patient-controlled analgesia device in the IN group was larger (mostly from 
24 to 48 h after surgery) than the EP group (12.0 +/- 5.54 mg versus 3.1 +/- 2.6 mg, 
respectively; P < 0.01). The incidence of vomiting was 4% in both groups, whereas the 
incidence of pruritus (16% versus 0%) and nausea (16% versus 4%) was more frequent in the 
IN group. No postdural puncture headache and no spinal hematoma occurred. They 
concluded that a single dose of intrathecal morphine followed by patient-controlled morphine 
analgesia can provide satisfactory postoperative pain relief after liver resection. The quality 
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of this treatment, according to the VAS, is not inferior to continuous epidural analgesia up to 
48 h after surgery (8). 
 
Duale, C. et al. (2003) studied on epidural versus intrathecal morphine for postoperative 
analgesia after Caesarean section. Combined spinal-epidural anaesthesia with 6 mg of IT 
hyperbaric bupivacaine plus sufentanil 5 microg, and additional ED lidocaine was used. 
Additionally, each patient received either 2 mg (2 ml) of ED morphine plus 1 ml of IT 
normal saline (ED group, n=28), or 0.075 mg (1 ml) of IT morphine plus 2 ml of ED normal 
saline (IT group, n=25). Additional postoperative analgesia was given in the form of 
propacetamol and ketoprofen, plus self-administered IV morphine. Results showed that; no 
major respiratory depression occurred. Time to first demand of morphine was similar in the 
ED (307.5 min) and IT. (310 min) groups, as was the incidence of side-effects such as 
sedation, pruritus, nausea, and vomiting. During the first 24 postoperative hours, VAS pain 
scores were greater in the IT group (P=0.032), as was additional morphine consumption (4 vs 
1.5 mg) (P=0.03). The study concluded that the ED protocol was more effective than the IT 
protocol, whilst side-effects were similar (9). 
 
Abouleish, E et al (1991) conducted a study to compare the efficacy and side effects of 0.2 
mg intrathecal (IT) morphine with 0.125% epidural bupivacaine in 62 women in labor. They 
were randomly divided into three groups: group 1 (n = 20) received IT morphine; group 2 (n 
= 22) received epidural bupivacaine; and group 3 (n = 20) received a combination of both 
using a combined spinal-epidural (CSE) technique. According to a visual analogue scale for 
assessing analgesia, neither IT 0.2 mg morphine nor 10 ml 0.125% epidural bupivacaine was 
effective in producing adequate pain relief in labor, whereas the combination produced 
excellent analgesia. The use of IT morphine significantly reduced the dosage requirement of 
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epidural bupivacaine. The incidence of nausea, vomiting, and pruritus was significantly 
higher when IT morphine had been administered, whereas that of urinary retention did not 
differ. No serious respiratory depression occurred in any of the patients. When the course of 
labor was studied, the prior use of IT morphine significantly prolonged the duration of the 
first stage of labor and the total duration of labor. They conclude that the administration of 
0.2 mg IT morphine in combination with epidural administration of 0.125% bupivacaine 
provides better analgesia than the administration of either drug alone (10). 
GENERAL OBJECTIVES 
To compare the analgesic efficacy between ITM and EB (epidural bupivacaine) for post oper
ative analgesia undergoing elective abdominal hysterectomy  
 
SPECIFIC OBJECTIVES 
1. To assess intensity of post operative pain using  visual analogue scale (VAS) at 1 hour
, 4 hour, 8 hour, 12 hour, 16 hour and 24 hour post surgery. 
2. To compare the time for first patient-controlled analgesia (PCA) demand between the 
two groups   
3. To compare total morphine consumption 
4. To compare length of hospital stay and time to early mobilization 
HYPOTHESIS 
1. Intensity of visual analogue scale (VAS) is less in ITM 
2. Time for first patient-controlled analgesia (PCA) demand is earlier in ITM  
3. Total morphine consumption is more in EB  
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4. Length of hospital stay and time to early mobilization is less in ITM 
 
RESEARCH METHODOLOGY 
 Study design: Prospective, randomized, observer-blinded, controlled clinical trial  
 Study period: August 2014 – August 2016 
 Study population: Elective surgical patients who are planned for general anaesthesia 
with endotracheal intubation  in Hospital Sultanah Bahiyah Alor Setar and Hospital 
Universiti Sains Malaysia (HUSM) 
 Study setting: General Operation theater Hospital Sultanah Bahiyah, Alor Setar, 
Kedah and General Operation Theater (OT) HUSM 
 Inclusion criteria: 
o ASA  I – II undergoing elective abdominal hysterectomy  under general anaest
hesia 
o Age 18 -60 years old 
 Exclusion criteria: 
o Patient with chronic pain treated with opioids 
o Patient with Coagulopathy 
o Patient who is contraindicated to spinal/epidural technique (bleeding disorder, 
neurologic dysfunction, systemic/local infection) 
o Known allergic to study drugs 
 Withdrawal criteria : 
-  patient decided  to withdraw  from  study  
- If adverse event occurs  
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- Death not related  to study conducted  which occurs during study period 
 
SAMPLE SIZE CALCULATION 
The sample size calculation is based on study by De Pietri, L.et al. (2006) which resulted a 
significant difference in consumption of iv morphine with a patient-controlled analgesia 
device in the intrathecal analgesia group was larger ( mostly from 24 to 48 hour after surgery) 
than the Epidural analgesia group (12.0 +/- 5.54 mg versus 3.1 +/- 2.6 mg, respectively; P < 
0.01)(8). We used Power and sample size software version 3.0.10 for the calculation and the 
outcome was as below: 
 We are planning a study of a continuous response variable from independent control 
and experimental subjects with 1 control(s) per experimental subject.  In a previous 
study the response within each subject group was normally distributed with standard 
deviation 5.5.  If the true difference in the experimental and control means is 8.9, we 
will need to study 13 experimental subjects and 13 control subjects to be able to reject 
the null hypothesis that the population means of the experimental and control groups 
are equal with probability (power) 0.9.   The Type I error probability associated with 
this test of this null hypothesis is 0.01. 
If we consider 20% drop out, the additional samples will be 5.2 (~ 6). Therefore the total sam
ples will be 32, which is 16 patients per group 
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METHODOLOGY 
 Approval from Ethics Committee of Universiti Sains Malaysia (USM) will be taken 
before enrollment of the patients 
 Eligibility of the patients will be screening during preoperative assessment round 
which is normally done at least a day prior to scheduled surgery 
 Written consent will be obtained from all selected patients who fulfill the inclusion 
and the exclusion criteria  
 All patients will be premedicated with midazolam 7.5mg orally on the operation day (
given in 1 hour before induction of anesthesia).  
 Consented Patients will be randomized into 2 arm group I ( ITM) and group E ( EB) 
using block randomization as below : 
 6 ballot cards will be put inside the envelope. Each of the cards state 6 
different sequences of grouping (AABB, BBAA, ABAB, BABA, 
ABBA, and BAAB). 
 1 card will be randomly taken each time by any nurse who assists 
general anaesthesia to decide the group for the first four patients. This 
will be followed by other cards until all 6 sequences are completed. 
This means that at the end of 6 randomized sequences, there will be an 
equal 12 patients in each groups with the total number of 24 samples. 
 The randomization will be continued again as above until the total 
samples of collection are completed 
 All patients will be given fluid preload 10 ml/kg normal saline or Hartman’s before 
going to OT in preoperative waiting area. 
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 In OT, standard monitoring will be placed (ECG, oxygen saturation, non invasive 
blood pressure, capnography). 
 Group I will receive:  
o Patient will receive single injection of intrathecal morphine 0.2mg with 0.5% 
bupivacaine 2.5mls.  
o Spinal anaesthesia will be conducted under aseptic technique in sitting 
position. 
o Site will be identified at the level L3/L4 or L4/L5 based on anatomical 
landmark. 
o Local anesthetic (lidocaine hydrochloride) 2mls will be injected for skin 
infiltration.  
o Using spinal needle either spinocan 25G or pencan 27G, 0.2mg morphine with 
2.5ml 0.5% bupivacaine will be given intrathecally after CSF backflow is 
obtained.  
 Group E will receive: 
o Patient will receive epidural analgesia.  
o Epidural catheter will be inserted at the level of L3/L4 or L4/L5 using loss of 
resistance technique with Touhy needle 18G after infiltration of local 
anaesthesia. 
o Distance from skin to epidural space is marked and epidural catheter will 
inserted into epidural space with bevel of the needle directed cephalad.  
o Then a test dose of 3mls lidocaine 2% + adrenaline 1:200,000 will be injected 
via the catheter to confirm placement and to exclude inadvertent intravascular 
or intrathecal placement.  
o About 10-12 mls of 0.25% bupivacaine will be given in titration before 
induction. 
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 Both groups will be assessed the level of analgesia, at least up to T6 dermatomes 
before starting general anaesthesia 
 The anaesthetic management of all patients will be standardized. For all patients, they 
will induce with IV propofol 2 mg/kg, IV fentanyl 2-3mcg/kg, IV rocuronium 
0.9mg/kg. Proper ETT size will be use for tracheal intubation. Anaesthesia will be 
maintained with sevoflurane in a 50% oxygen; air mixture with minimal flow 
ventilation.  
 Intraoperative analgesia, the epidural group will be provided continuous epidural 
infusion 0.1% bupivacaine + fentanyl 2 µg/ ml, run at 6-12 ml/hr.  
 a decrease in blood pressure by more than 30% less than preoperative value in both 
group will be corrected with fluids , IV ephedrine or both.  
 Post operatively, patient will be observed in the recovery area. In epidural group, 
epidural analgesia continues with infusion 0.1% bupivacaine + fentanyl 2 µg/ ml at 6-
12ml/hr.  
 Both groups will be prepared, IV PCA morphine pump with lockout time 5 minutes, 
dilution 1mg/ml. No background infusion will be provided. 
 In the ward, pain assessment will be done during 1st hour post operative and then 4 
hourly up to 24hrs. VAS with 0 (no pain) to 10 (worst pain) will be used. 
 First PCA demand and total consumption of rescue PCA morphine will be recorded. 
 Post operative nausea/vomiting will be recorded and IV metoclopramide 10mg every 
8 hours and chlorpeneramine will be given for pruritus. Other side effects will be 
noted. 
 Patient’s outcome and patient satisfaction regarding pain management will be 
evaluated. 
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ASSESSMENT 
 Pain score using VAS (visual analog scale) in both group 
 The total morphine consumption post operative 
 Haemodynamic parameters: post administration of drugs (intrathecal morphine / 
epidural). Blood pressure and heart rate will be monitored every 5 minutes 
intraoperatively.  
 Side effect of the drugs will be recorded including nausea, vomiting, pruritus, 
respiratory depression and patient sedation.  
 Patient’s satisfaction and outcome will be noted 
 
ADVERSE EVENT 
Adverse effects reported from drug product information are listed below: 
MORPHINE 
 Nausea 
 Vomiting 
 Constipation  
 Drowsiness 
 Respiratory depression 
 Hypotension 
 Pruritus, urticaria 
 Difficulty in micturition, sweating, vertigo 
 Facial flushing , palpitation, dependence, miosis 
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PIVIKAN (plain bupivacaine) 
 High / total spinal blockade 
 Acute systemic toxicity 
 Allergy 
 Neurological reaction 
Should any adverse reaction occurred, the symptoms will be managed accordingly and patien
t will be followed up until symptoms resolved 
SERIOUS ADVERSE EVENT 
A serious adverse event is considered when any adverse events that result in any of the follo
wing outcomes: 
 Death 
 A life threatening adverse event 
 In patient hospitalization or prolonging existing hospitalization 
 A persistent or significant disability/incapacity 
 
Should any of those incident happen, relevant action will be taken and investigator will send r
eport to relevant body base on guideline provide by CRC 
STATISTICAL ANALYSIS 
All analysis will be using SPSS software version 19. Data were tested for normal 
distribution. Demographic and clinical data were compared by means of 
Independent samples Student’s t-test, or chi-square test if appropriate. 
Differences were considered as significant with P < 0.05.  
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FLOW CHART 
Approval from Ethics Committee  
 
Preoperative assessment & screening 
   
Enrollment of the patients (based on inclusion and exclusion criteria) & written consent 
  
 Premedication (midazolam 7.5mg orally)  
 
In operation theatre: 
 Standard monitoring will be attached (NIBP, SPO2, ECG, ETCO2) 
 Preoxygenation 
 block Randomization technique into  2 groups   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Group E (EB) 
 About 10-12mls of 0.25% 
plain bupivacaine 
 
Group I (ITM): 
 intrathecal morphine 0.2mg 
with 0.5% bupivacaine 2.5mls 
Assessment: 
1. Intraoperative hypotensive episodes   
2. Intraoperative total fluid intake  
3. Intensity of visual analog scale (VAS)  
4. Time for first patient-controlled analgesia (PCA) de
mand  
5. Total morphine consumption  
6. Time to early mobilization  
7. Length of hospital stay  
8. Proportion of side effects 
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